Skip to main content

Animations

MJFF Publications

5421 - 5430 of 9148 Results
Title
Year
  • Year
  • 2018
  • 2017
  • 2015
  • 2012
  • 2023
  • 2025
  • 2016
  • 2021
  • 2015
  • 2019
  • Summary Details
    OPEN
    Title: Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2018.03.012
    Citation Count: 199
  • Summary Details
    RESTRICTED
    Title: Increased odds of bladder and bowel symptoms in early Parkinson's disease
    Journal Name: Neurourology and Urodynamics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/nau.23443
    Citation Count: 12
  • Summary Details
    OPEN
    Title: 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddv453
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2012.03.038
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Toward Omics-Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue Using a Multiclass Internal Standard Mixture
    Journal Name: Analytical Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.analchem.3c02724
    Citation Count: 46
  • Summary Details
    OPEN
    Title: α-Synuclein seed amplification assay positivity beyond synucleinopathies
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105925
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0072-9
    Citation Count: 290
  • Summary Details
    OPEN
    Title: Retrospective motion artifact correction of structural MRI images using deep learning improves the quality of cortical surface reconstructions
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2021.117756
    Citation Count: 98
  • Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial
    2015
    Summary Details
    OPEN
    Title: Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00008-3
    Citation Count: 186
  • Summary Details
    OPEN
    Title: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriers
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.24543
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.